Part,  Chapter, Paragraph

 1    I,     2.  2        |                      to a variety of hazardous agents and made the prevention
 2    I,     2. 10.  2    |                        as imaging and contrast agents;~- Polymer nanoparticles:
 3   II,     5.  5.  3    |                      on Clinical Trials on New Agents in Multiple Sclerosis. Neurology
 4   II,     5.  6.  3    |                     less effective therapeutic agents than those currently used.~ ~
 5   II,     5.  7.  7    |              hypertension and antihypertensive agents in chronic kidney disease.
 6   II,     5.  8.  1    |                            Exposure to noxious agents (e.g. tobacco active and
 7   II,     5.  8.  2    |                       diseases due to external agents ( J6 )~J44.0~ ~Chronic obstructive
 8   II,     5.  9.  4    |                        to chemical or biologic agents at workplace (isocyanates,
 9   II,     5. 11.  3    |                 palladium are also sensitizing agents. The ESSCA data revealed
10   II,     6.  3.  2    |                      to the two most effective agents against TB, isoniazid and
11   II,     6.  3.  6    |                       which infectious disease agents can spread. Changes in consumer
12   II,     6.  4.  5    |                   prudent use of antimicrobial agents in human medicine. The European
13   II,     6.  4.  5    |                      exposure to antimicrobial agents may occur not only through
14   II,     6.  4.  5    |                    resistance to antimicrobial agents and evaluate the effects
15   II,     6.  4.  5    |                   consumption of antimicrobial agents in all sectors. These surveillance
16   II,     6.  4.  5    |                   consumption of antimicrobial agents for the evaluation of policy
17   II,     6.  4.  5    |                     the need for antimicrobial agents and to promote the prudent
18   II,     6.  4.  5    |                        the prudent use of such agents. These include: a) increase
19   II,     6.  4.  5    |                        misuse of antimicrobial agents; c) make sure that antibacterial
20   II,     6.  4.  5    |                      and replace antimicrobial agents used with different purposes
21   II,     6.  4.  5    |               development of new antimicrobial agents, alternative treatments
22   II,     6.  4.  5    |                  alternatives to antimicrobial agents.~ ~· international cooperation:
23  III,    10.  1        |                        1. Health determinants: agents, exposure routes, human
24  III,    10.  1        |                   factors influencing health~ ~AGENTS~EXPOSURE ROUTES~LIVING AND
25  III,    10.  2.  1    |                    Commission, 2005). The main agents for fighting osteoporosis
26  III,    10.  2.  4    |                       factors such as chemical agents, nutrition or personal behaviour
27  III,    10.  3.  1    |                               10.3.1. Physical agents~ ~
28  III,    10.  3.  2    |                               10.3.2. Chemical agents~ ~
29  III,    10.  3.  2    |                     products (such as cleaning agents, personal care products,
30  III,    10.  3.  3    |                             10.3.3. Biological agents~ ~
31  III,    10.  3.  3    |                       more recently discovered agents such as prions; often, they
32  III,    10.  3.  3    |                      most dangerous biological agents for human health. Seasonal
33  III,    10.  4.  1    |                     paints, household cleaning agents, environmental tobacco smoke
34  III,    10.  4.  1    |                         biological or physical agents. Many outdoor air pollutants
35  III,    10.  4.  1    |                        and the use of cleaning agents, disinfectants and air-cleaners.
36  III,    10.  4.  1    |                       fragrances from cleaning agents and other household products
37  III,    10.  4.  2    |                       occurrence of infectious agents such as Salmonella, as well
38  III,    10.  4.  2    |                        chemical and biological agents potentially present in food (
39  III,    10.  4.  2    |                        important for hazardous agents (see also Section 4.14.2).~ ~
40  III,    10.  4.  2    |                          Zoonoses and zoonotic agents ~ ~Regulation No 882/2004
41  III,    10.  4.  2    |                 specific zoonoses and zoonotic agents to the Commission each year.
42  III,    10.  4.  2    |                       of zoonoses and zoonotic agents29 lays down the rules for
43  III,    10.  4.  2    |                       on zoonoses and zoonotic agents in animals, foodstuffs and
44  III,    10.  4.  2    |                       yersiniosis;~• parasitic agents: anisakiasis, cryptosporidiosis,
45  III,    10.  4.  2    |                       and~• other zoonoses and agents thereof.~ ~Food-borne outbreaks
46  III,    10.  4.  2(29)|                       of zoonoses and zoonotic agents, amending Council decision
47  III,    10.  4.  2    |                       on zoonoses and zoonotic agents collected under directive
48  III,    10.  4.  2    |                     options for other zoonotic agents.~Whereas Directive 2003/
49  III,    10.  4.  2    |               pathogens by monitoring zoonotic agents throughout the food and
50  III,    10.  4.  2    |               occurrence of zoonoses, zoonotic agents, antimicrobial resistance
51  III,    10.  4.  2    |                      the most common causative agents of food-borne virus outbreaks.
52  III,    10.  4.  2    |                   residues of plant protection agents and fertilizers in agriculture,
53  III,    10.  4.  2    |                medicines~ ~ ~ ~ ~Antibacterial agents~Residues in meat~Development
54  III,    10.  4.  2    |                        formulation of grouting agents. A large-scale use of acrylamide
55  III,    10.  4.  2    |                      acrylamide based grouting agents occurred at Hallandsasen,
56  III,    10.  4.  2    |                  sources of zoonoses, zoonotic agents, antimicrobial resistance
57  III,    10.  4.  3    |                      of pharmaceuticals. These agents are directly transmitted
58  III,    10.  4.  3    |                      on the specific causative agents, although such events occur
59  III,    10.  4.  3    |                      The most common causative agents were bacterial (Campylobacters,
60  III,    10.  4.  3    |                      cases of illnesses. Viral agents were implicated in 20 outbreaks (
61  III,    10.  4.  4    |                        care products, cleaning agents, electronics, clothing,
62  III,    10.  5.  3    |                    risks arising from physical agents (noise), which replaces
63   IV,    11.  3.  2    | priority-list-of-diseases, are anti-neoplastic agents (figure 11.5).~ ~Therapeutic
64   IV,    11.  3.  2    |           anti-neoplastic and immunomodulating agents remaining dominant and representing
65   IV,    11.  6.  2    |                       population.~ ~Collection agents vary across social insurance
66   IV,    11.  6.  2    |                      payments (see below). The agents collecting PHI premiums
67   IV,    11.  6.  4    |                        are multiple collection agents as in some countries with
68   IV,    11.  6.  4    |                         the revenue collection agents are also the purchasers (
69   IV,    12.  4        |                      safety of tooth whitening agents, the assessments of possible
70   IV,    12.  4        |                   information to policy making agents and the public.~EFSA~ ~European
71  Key,   Ap5.  0.  0    |               aetiology~aflatoxin~ageing~agent~agents~aggression~agriculture~agrochemicals~